What is Austar Lifesciences Gross-Profit-to-Asset %?
Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Austar Lifesciences's annualizedGross Profit for the quarter that ended in Dec. 2023 was HK$413 Mil.
Austar Lifesciences's average Total Assets over the quarter that ended in Dec. 2023 was HK$2,440 Mil. Therefore, Austar Lifesciences's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2023 was 16.93%.
Austar Lifesciences Gross-Profit-to-Asset % Historical Data
The historical data trend for Austar Lifesciences's Gross-Profit-to-Asset % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Austar Lifesciences's Gross-Profit-to-Asset %
For the Medical Devices subindustry, Austar Lifesciences's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Austar Lifesciences's Gross-Profit-to-Asset % Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Austar Lifesciences's Gross-Profit-to-Asset % distribution charts can be found below:
* The bar in red indicates where Austar Lifesciences's Gross-Profit-to-Asset % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data,
the Gross Profit data used here is two times the semi-annual (Dec. 2023) data.
Gross-Profit-to-Asset % is displayed in the 30-year financial page.
Austar Lifesciences Gross-Profit-to-Asset % Related Terms
Thank you for viewing the detailed overview of Austar Lifesciences's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.
Austar Lifesciences (HKSE:06118) Business Description
Austar Lifesciences Ltd is a China-based company engaged in providing engineering solutions to pharmaceutical manufacturers and research institutes. The business activity of the group is operated through Liquid and Bioprocess Systems; Clean Room and Automation Control and Monitoring Systems; Powder and Solid Systems; Good Manufacturing Practice (GMP) Compliance Service; Life Science Consumables; and Distribution and Agency of Pharmaceutical Equipment segments. It derives the majority of revenue from the Liquid and Bioprocess System segment which is involved in providing solutions in pharmaceutical and water systems to treat water. The geographical business presence of the firm is seen across China and in other countries.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
HKSE:06118 has been successfully added to your 